Diabetes medications exposure reduces risk of MS in female patients below age of 45 years Dr. Kamal Kant Kohli19 Nov 2022 9:00 AM ISTResearchers at University of Arizona Health Sciences have found in a new study that people older than 45 whose Type 2 diabetes was treated with...
Paleolithic and Mediterranean diets reduce fatigue in Multiple Sclerosis Dr.Niharika Harsha B28 Oct 2022 8:00 PM ISTA recent network meta-analysis revealed that Paleolithic and Mediterranean diets may reduce Multiple Sclerosis related fatigue and improved physical...
US Supreme Court turns down Novartis bid to block launch of multiple sclerosis drug Gilenya generics Ruchika Sharma15 Oct 2022 1:30 PM ISTNovartis settled with some of the drugmakers it had sued, allowing for some Gilenya generics before a key patent's 2027 expiration.
Latitude and UVB exposure linked to multiple sclerosis severity: study Dr. Hiral patel22 Sept 2022 9:45 AM ISTAustralia: Severity of multiple sclerosis (MS) is associated with latitude and this association is partly driven by UVB exposure contributing to both...
Ubituximab cuts relapse rate and extent of brain lesions among patients with recurrent MS: NEJM Dr. Kamal Kant Kohli30 Aug 2022 9:45 AM ISTUSA: When compared to teriflunomide, a frequently recommended oral treatment for multiple sclerosis, ubituximab, an experimental targeted B-cell...
Surprising way in which Multiple sclerosis drugs works Isra Zaman13 Aug 2022 9:45 AM ISTCells that make myelin are sensitive to adenosine triphosphate (ATP) and nitric oxide (NO), molecules that are present in high amounts in the blood...
Health Bulletin 12/July/2022 Dr. Nandita Mohan12 July 2022 5:47 PM ISTHere are the Top health stories for the day:ICMR launches national registry of multiple sclerosis and allied demyelinating disordersThe Indian...
USFDA places clinical hold on Phase 3 Tolebrutinib studies: Sanofi Ruchika Sharma2 July 2022 12:45 PM ISTThe FDA action was based on a limited number of cases of drug-induced liver injury that have been identified with tolebrutinib exposure in Phase 3...
Setback to Novartis: US Court declares multiple sclerosis drug Gilenya patent invalid Ruchika Sharma22 Jun 2022 12:30 PM ISTNovartis also said it believes HEC and others cannot launch generic versions of Gilenya during the ongoing appeal process.
Keto-Diet, A Better Nutritional Approach for MS Patients MD Bureau2 May 2022 10:30 AM ISTObesity is a recognized risk factor for multiple sclerosis (MS) and, dietary intake is one potentially modifiable environmental contributor...
Use of MS drug Glatiramer acetate by breastfeeding mothers safe for offsprings Medical Dialogues Editorial Team16 April 2022 9:00 AM ISTDelhi: Glatiramer acetate use by mothers during nursing had no negative effects on child safety outcomes examined throughout the first 18 months of...
Masitinib may delay disability progression in multiple sclerosis Medical Dialogues Editorial Team29 March 2022 9:00 AM ISTSpain: In a new study, it was found that masitinib 4.5 mg/kg/d reduced disability progression in individuals with patients with primary progressive...
